CCM
LFCR icon

Corsair Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Corsair Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$147K – 174
2025
Q3 		$147K Buy
+20,000
New +$151K 0.02% 146
2023
Q3 		– Sell
-122,431
Closed -$1.18M – 112
2023
Q2 		$1.18M Sell
122,431
-2,497
-2% -$15.2K 0.4% 28
2023
Q1 		$472K Buy
+124,928
New +$696K 0.18% 52

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Corsair Capital Management's LFCR Position: Q4 2025 in Review

Corsair Capital Management sold out of Lifecore Biomedical (LFCR) in Q4 2025, closing a stake of 20,000 shares — an estimated $147K sold.

Corsair Capital Management first reported a position in LFCR in Q1 2023 and held it in 3 quarters. The position peaked at $1.18M in Q2 2023. 103 funds tracked by Wall St. Rank hold LFCR as of Q4 2025.

  • Corsair Capital Management reported no remaining Lifecore Biomedical position as of Q4 2025 after selling out during the quarter.
  • Corsair Capital Management sold 20,000 Lifecore Biomedical shares in Q4 2025, an estimated $147K.
  • Corsair Capital Management first reported a position in Lifecore Biomedical in Q1 2023 and held it in 3 quarters.
  • Corsair Capital Management's Lifecore Biomedical position peaked at $1.18M in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2025.

Based on Corsair Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.